The 9th Clinical Biomarkers & World CDx Boston 2018 summit is once again the home for the biomarker, translational and diagnostic community to accelerate the translation from exploratory biomarker into clinically validated signature and ultimately a proven, predictive IVD. Join Evidera’s Daryl Spinner, PhD, MBA, Managing Director, Real-World Value and Strategy as he participates on the issue panel Overcoming Hurdles in Reimbursement & Access for Diagnostic Enabled Therapeutics.
